Inhibitor of Apoptosis (IAP) Proteins: Novel Insights into the Cancer-Relevant Targets for Cell Death Induction
Author(s) -
Simone Fulda
Publication year - 2009
Publication title -
acs chemical biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.899
H-Index - 111
eISSN - 1554-8937
pISSN - 1554-8929
DOI - 10.1021/cb900150g
Subject(s) - xiap , inhibitor of apoptosis , apoptosis , programmed cell death , cancer research , cancer cell , cancer , inhibitor of apoptosis domain , biology , chemistry , microbiology and biotechnology , caspase , biochemistry , genetics
Inhibitor of apoptosis (IAP) proteins are expressed at high levels in various cancers and block apoptosis at a key node. Therefore, there is currently much interest in IAP antagonists as cancer therapeutics. Structure-based development of selective IAP inhibitors now provides, for the first time, evidence that simultaneous inhibition of the c-IAP proteins and XIAP is necessary for efficient induction of cancer cell death by IAP antagonists.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom